VYNE Therapeutics Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
VYNE on Nasdaq
Location
685 Route 202/206 N., Suite 301, Bridgewater, NJ

Insiders trading volume in the past year

VYNE Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Perceptive Advisors Llc 10%+ Owner $11.3M Aug 16, 2021
AI Biotechnology LLC 10%+ Owner $2.55M Nov 1, 2023
Andrew Saik Chief Financial Officer $266K May 28, 2021
Matthew T. Wiley Chief Commercial Officer $249K Jun 30, 2021
Patrick G. Lepore Director $150K +$43.8K +41.1% Jan 15, 2025
David Domzalski PRESIDENT AND CEO, Director $144K Sep 30, 2025
Mutya Harsch Chief Legal Officer And Gc $43.4K Sep 30, 2025
Iain Stuart Chief Scientific Officer $39.4K Sep 30, 2025
Tyler Zeronda Chief Financial Officer $37.4K Sep 30, 2025
Steven L. Basta Director Dec 12, 2024
Christine Borowski Director Dec 12, 2024
Anthony D. Bruno Director Dec 12, 2024
Elisabeth Sandoval Director Dec 12, 2024
Rex Bright Director Jul 19, 2021
Sharon Barbari Director Dec 12, 2024

Recent Insider Transactions by Companies or Individuals for VYNE Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.